X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213427
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213447
https://www.expresspharma.in/zydus-cadila-receives-tentative-approval-from-us-fda-for-eluxadoline-tablets/
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-viberzi-206940-eluxadoline-tablets-75-mg-and-100-mg-1564811438.pdf
http://www.prnewswire.com/news-releases/allergan-reports-new-data-reinforcing-the-effectiveness-of-viberzi-eluxadoline-to-treat-the-symptoms-associated-with-irritable-bowel-syndrome-with-diarrhea-ibs-d-abdominal-pain-and-diarrhea-300485192.html
http://raps.org/Regulatory-Focus/News/2017/03/15/27114/FDA-Warns-of-Increased-Risk-of-Serious-Pancreatitis-with-Allergan%E2%80%99s-Viberzi/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
http://www.fiercepharma.com/marketing/allergan-ceo-2017-should-be-kybella-s-breakout-year
http://www.fiercepharma.com/marketing/valeant-looks-to-revive-xifaxan-primary-care-sales-effort-will-it-work
http://www.fiercepharma.com/marketing/allergan-teams-star-paratriathlete-yet-another-effort-to-boost-ibs-d-med-viberzi
http://www.fiercepharma.com/pharma/allergan-s-handling-black-eye-q3-hurts-confidence-management-analyst
http://www.fiercepharma.com/marketing/allergan-teams-up-ibs-d-platform-to-identify-potential-new-viberzi-patients
https://www.pharmacompass.com/pdf/news/Aptalis-Pharma-SAS-Truberzi-Eluxadoline-Approved-In-Europe-1475235359.pdf
http://www.prnewswire.com/news-releases/allergan-receives-positive-opinion-for-truberzi-eluxadoline-for-treatment-of-irritable-bowel-syndrome-with-diarrhoea-ibs-d-in-adults-300303267.html
http://www.fiercepharma.com/marketing/allergan-s-stellar-viberzi-coverage-bodes-well-for-future-launches-analyst
http://www.fiercepharma.com/marketing/allergan-continues-viberzi-push-online-ibs-d-awareness-tool
http://www.fiercepharmamarketing.com/story/vexing-ibs-d-spokescharacter-irritabelle-headlines-allergans-viberzi-ad-pus/2016-04-11
http://www.prnewswire.com/news-releases/viberzi-eluxadoline-phase-iii-trial-results-published-in-the-new-england-journal-of-medicine-300207672.html
http://www.europeanpharmaceuticalreview.com/37272/news/industry-news/allergans-viberzi-eluxadoline-now-available-in-the-us/?
http://www.fiercepharmamarketing.com/story/love-it-or-hate-it-valeants-wobbly-pink-gut-guy-xifaxan-getting-noticed/2015-12-10
http://www.fiercepharmamarketing.com/story/allergan-pumps-its-sales-rep-tally-amid-viberzi-launch-aesthetics-push/2015-11-05
http://www.fiercepharma.com/story/allergan-cuts-h2-sales-forecast-10-growth-tap-2016/2015-09-29
Market Place
Share 
